FDA draft guidance to improve clinical trial diversity: Opportunities for pharmacoepidemiology
- DOI
- 10.1017/cts.2023.515
- Published
- 2023
- Container
- Journal of Clinical and Translational Science
- Publisher
- Cambridge University Press (CUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1017/cts.2023.515,
title = {FDA draft guidance to improve clinical trial diversity: Opportunities for pharmacoepidemiology},
author = {Elizabeth S. Russell and Elodie Aubrun and Daniela C. Moga and Sandra Guedes and Wendy Camelo Castillo and Janet R. Hardy and J. Alexander Cole and Oladayo Jagun},
year = {2023},
journal = {Journal of Clinical and Translational Science},
doi = {10.1017/cts.2023.515},
url = {https://doi.org/10.1017/cts.2023.515}
}RIS
TY - JOUR TI - FDA draft guidance to improve clinical trial diversity: Opportunities for pharmacoepidemiology AU - Elizabeth S. Russell AU - Elodie Aubrun AU - Daniela C. Moga AU - Sandra Guedes AU - Wendy Camelo Castillo AU - Janet R. Hardy AU - J. Alexander Cole AU - Oladayo Jagun PY - 2023 JO - Journal of Clinical and Translational Science DO - 10.1017/cts.2023.515 UR - https://doi.org/10.1017/cts.2023.515 ER -
APA
Russell, E. S., Aubrun, E., Moga, D. C., Guedes, S., Castillo, W. C., Hardy, J. R., Cole, J. A., & Jagun, O. (2023). FDA draft guidance to improve clinical trial diversity: Opportunities for pharmacoepidemiology. Journal of Clinical and Translational Science. https://doi.org/10.1017/cts.2023.515
Source records
- crossref · retrieved 2026-09-26T11:28:03.134Z